
Reverse Vaccinology
Concept, Methods and Advancement
- 1st Edition - July 6, 2024
- Imprint: Academic Press
- Editors: Jayashankar Das, Sushma Dave, Siomar de Castro Soares, Sandeep Tiwari
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 3 9 5 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 3 9 6 - 1
Reverse Vaccinology: Concept, Methods, and Advancement presents the development strategy of new vaccines through genome sequencing bioinformatics analysis. This book promis… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteThis book is split into three sections: the first, Concept, brings the basis of reverse vaccinology, vaccine antigen discovery, and subunit vaccine; the second, Tools and Methods, describes immunoinformatic, proteomics for epitope-vaccine design, databases, network analysis, machine learning, and NGS-driven antigen screening technology; and the last one, Disease Case Study, discusses real-world examples in the development of new vaccines for diverse diseases.
It is a valuable resource for bioinformaticians, researchers, students, and members of the biomedical and medical fields who want to learn more about a new and agile process for the development of new vaccines.
- Explains the fundamentals of reverse vaccinology and how it can save time in the development of new vaccines
- Focuses on the efforts to develop a vaccine candidate against various pathogens using computational approaches
- Presents databases and web servers for conducting reverse vaccinology
- Describes the screening process of potential vaccine candidate through machine learning
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- About the editors
- Preface
- Section 1: Concept
- Chapter 1. Fundamentals of reverse vaccinology: history and advantages over the discovery of conventional vaccine candidates
- Abstract
- 1.1 Immune system
- 1.2 Classical vaccinology
- 1.3 Omics and reverse vaccinology
- 1.4 Conclusion
- References
- Chapter 2. Vaccine antigen discovery: a breakthrough in genomic era
- Abstract
- 2.1 Introduction
- 2.2 Conventional vaccines to biotechnological vaccines
- 2.3 Antigen discovery by reverse vaccinology
- 2.4 Conclusion
- References
- Chapter 3. Development of subunit vaccine: A step forward toward cost-effective technology of vaccine candidate discovery
- Abstract
- 3.1 Introduction
- 3.2 Importance of subunit vaccines in vaccine discovery
- 3.3 Advantages of subunit vaccines over conventional treatments
- 3.4 Methods for discovering antigenic determinants
- 3.5 Development and testing of subunit vaccines
- 3.6 Potential benefits of subunit vaccines
- 3.7 Conclusion
- References
- Section 2: Tools and Methods
- Chapter 4. Machine learning approach for vaccine development-fundamentals
- Abstract
- 4.1 Introduction
- 4.2 Classification of machine learning algorithms
- 4.3 Clustering
- 4.4 Dimensionality reduction
- 4.5 Regression
- 4.6 Classification
- 4.7 Conclusion
- References
- Chapter 5. Immunoinformatics: an interdisciplinary technique for designing and engineering vaccine antigen
- Abstract
- 5.1 Introduction
- 5.2 Development of a multiepitope vaccine
- 5.3 Evaluation of antigenic, allergenic, immunogenicity, and toxicity
- 5.4 Population coverage analysis
- 5.5 Molecular docking
- 5.6 Molecular dynamic prediction
- 5.7 Construction of the peptide vaccine
- 5.8 Future challenges and conclusion
- References
- Chapter 6. Proteomics for epitope-based vaccine design
- Abstract
- 6.1 Introduction
- 6.2 Western blotting and two-dimensional gel electrophoresis
- 6.3 Enzyme-linked immunosorbent assay
- 6.4 Phage display
- 6.5 Immunoprecipitation and epitope extraction
- 6.6 Mass spectrometry in proteomics
- 6.7 Proteomics workflows
- 6.8 Posttranslational modifications
- 6.9 Proteogenomics
- 6.10 Conclusion
- References
- Chapter 7. Databases and web server for conducting reverse vaccinology
- Abstract
- 7.1 Introduction
- 7.2 Online tools and web servers
- 7.3 Databases for reverse vaccinology
- 7.4 In silico case study: reverse vaccinology on Mycoplasma genitalium
- 7.5 Conclusions
- References
- Chapter 8. Bacterial dynamics and network analysis for antigen screening
- Abstract
- 8.1 Background
- 8.2 Systematic biology and network analysis
- 8.3 Genome annotation
- 8.4 Pangenomic tools
- 8.5 Gene transfer analysis tools
- 8.6 Conclusion
- References
- Chapter 9. Tools and platform for allergenicity prediction
- Abstract
- 9.1 Introduction
- 9.2 Databases and tools for allergens/allergenicity prediction
- 9.3 Case studies
- 9.4 Conclusion
- Ethics declarations
- Financial interests
- Conflicts of interest
- References
- Chapter 10. Screening of potential vaccine candidates through machine learning approach
- Abstract
- 10.1 Introduction to machine learning
- 10.2 Training of a machine learning model
- 10.3 Machine learning approaches
- 10.4 Performance measures
- 10.5 Applications of machine learning in reverse vaccinology
- 10.6 Conclusion and prospects
- References
- Chapter 11. Reverse vaccinology 2.0: computational resources for B-cell epitope prediction
- Abstract
- 11.1 Introduction
- 11.2 Prediction of linear (continuous) B-cell epitopes
- 11.3 Prediction of conformational (discontinuous) B-cell epitopes
- 11.4 Case studies
- 11.5 Conclusion
- Abbreviations
- Funding
- Data availability statement
- Declaration of competing interest
- References
- Chapter 12. Structural vaccinology approaches to enhance efficacy, stability, and delivery of protective antigens
- Abstracts
- 12.1 Introduction
- 12.2 Challenges in structure-based design of improved viral antigens
- 12.3 Phosphorylcholine
- 12.4 Malondialdehyde
- 12.5 Natural antibodies
- 12.6 Hepatitis C virus
- 12.7 Respiratory syncytial virus
- 12.8 Influenza virus
- 12.9 Dengue virus
- 12.10 Masking of nonneutralizing epitopes
- 12.11 Improvement of vaccine thermostability
- 12.12 Structural vaccinology pitfalls
- 12.13 Conclusion
- References
- Chapter 13. Next-gen sequencing-driven antigen screening technology in vaccine development
- Abstract
- 13.1 Introduction
- 13.2 Next-generation sequencing—a platform for screening the antigens
- 13.3 Artificial intelligence and machine learning—in silico–derived vaccines
- 13.4 Next-generation sequencing revolution in collective high-performance computing systems
- 13.5 Reverse vaccinology approach against antibiotic-resistant bacteria
- 13.6 Conclusion
- References
- Section 3: Disease Case Study
- Chapter 14. Bioinformatics approach to design peptide vaccines for viruses
- Abstract
- 14.1 Introduction
- 14.2 Foot-and-mouth disease context
- 14.3 Foot-and-mouth disease vaccines over the years
- 14.4 Reverse vaccinology applied to foot-and-mouth disease
- 14.5 Advances in computational vaccine development against foot-and-mouth disease virus
- 14.6 Adopting different strategies in reverse vaccinology against foot-and-mouth disease
- 14.7 Challenges and perspectives
- 14.8 Conclusion
- References
- Chapter 15. Confirmation of candidates identified by reverse vaccinology in animal models or other immunogenicity assays
- Abstract
- 15.1 Introduction
- 15.2 Stages of vaccine development
- 15.3 In vivo tests
- 15.4 In vitro tests
- 15.5 Conclusions and perspectives
- References
- Chapter 16. Clinical trials of vaccines incorporating antigens identified from a reverse vaccinology approach
- Abstract
- 16.1 Introduction
- 16.2 Reverse vaccinology
- 16.3 Clinical trials
- 16.4 New approaches
- 16.5 Conclusion
- References
- Chapter 17. Developing meningococcal and bacterial vaccines using reverse vaccinology Review on the development of the meningococcal and bacterial vaccines (Streptococcus and Staphylococcus) using reverse vaccinology
- Abstract
- 17.1 Meningococcal diseases
- 17.2 Bacteremic pneumonia
- 17.3 Staphylococcus aureus infections
- References
- Index
- Edition: 1
- Published: July 6, 2024
- Imprint: Academic Press
- No. of pages: 600
- Language: English
- Paperback ISBN: 9780443133954
- eBook ISBN: 9780443133961
JD
Jayashankar Das
Dr. Das received his PhD in biotechnology and served as a Scientist at the IBSD, DBT, Government of India. He is the Founder and CEO of Valnizen which deals with regulatory documents and healthcare compliances and support services to African and southeast Asian countries. He has served as a Joint Director of the Gujarat State Biotechnology Mission, DST, and Joint Director to Gujarat Biotechnology Research Centre, DST, both from the Government of Gujarat. He has served as a Director of the Savli Technology and Business Incubator, DST, Government of Gujarat, India. He was actively involved in the development and implementation of various policies and action plans like biotechnology policy, innovation policy, interpole disaster management policy, start-up policy for many universities and governments. His research team is involved in addressing societal challenges via cutting-edge research, namely, the development of molecular diagnostics for infectious diseases, the development of universal vaccine candidate for emerging diseases, the development of miRNA-based targeted therapeutics, and artificial intelligence in healthcare applications.
SD
Sushma Dave
Dr. Sushma Dave received a master of science and PhD in analytical, electrochemistry, and environmental chemistry from the Biosensor Lab in the Chemistry Department of Jai Narayan Vyas University, Jodhpur. She is involved continuously in the field of higher education teaching pure, applied chemistry, cheminformatics, nanotechnology, electrochemistry, biology, solid waste management, wastewater treatment, and environmental chemistry to students of engineering and basic sciences. She also served as a Research Associate in the Soil Biochemistry and Microbiology Division, CAZRI, Jodhpur. She has published and presented over 50 papers in international and national journals, conferences and participated in various workshops and training programs. Her areas of interest are electrochemistry, biosensors environmental science, nanotechnology, biochemistry, cheminformatics, immunoinformatics, and drug repurposing.
SS
Siomar de Castro Soares
Dr. Soares obtained his MSc and PhD in genetics from the Federal University of Minas Gerais with 1-year experience in the Center for Biotechnology (CeBiTec) of Universität Bielefeld. He obtained a second PhD and postdoc research in bioinformatics. He was a Senior Bioinformatics’ Researcher at the Official Laboratory of the Ministry of Fisheries. Dr. Soares is currently Secretary of the Southeast Regional of the Brazilian Society of Genetics (2017–present), Substitute Coordinator of the Bachelor’s in Biomedicine of UFTM (2017–present), Director of the Department for the Development of Research and Technological Innovation of UFTM (2019–present), and Affiliate Member of the Brazilian Academy of Sciences (2018–present). His areas of expertise are molecular genetics, genomic sequencing, and microbial comparative genomics, mainly focused on pan-genomics, the role of pathogenicity islands and virulence factors in genome plasticity, phylogenomics, molecular epidemiology, reverse vaccinology, and software development (Perl and Java languages).
ST
Sandeep Tiwari
Dr. Tiwari obtained his BSc from Deen Dayal Upadhyaya Gorakhpur University, MSc in bioinformatics from Devi Ahilya University, and PhD in bioinformatics from the Department of Genetics, Ecology and Evolution, Federal University of Minas Gerais, Brazil. He is a Guest Associate Editorial Board of Frontier in Genetics and frequently serves as an external reviewer for PeerJ and Frontiers. His main areas of expertise are molecular genetics, genomic sequencing, and comparative genomics of microorganisms, with a focus on pan-genomics, genomic plasticity in the identification of pathogenicity islands and virulence factors for drug discovery, phylogenomic, molecular epidemiology, reverse vaccinology, and immunoinformatic.